Volume 22 Number 4 | 2007
- DEA rule change on frequency of prescribing controlled substances
- Anabolic steroids and performance-enhancing drugs
- Weight loss clinics cause concern for the Board
- Resigning hospital privileges may have unintended consequences
- Over-the-counter insulin users may forego regular doctor visits